U.S. markets open in 14 minutes

Nabriva Therapeutics plc (NBRV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.3500-0.0200 (-1.46%)
At close: 4:00PM EDT

1.4200 +0.07 (5.19%)
Pre-Market: 9:06AM EDT

Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts1122
Avg. Estimate-0.43-0.39-1.66-1.1
Low Estimate-0.43-0.39-1.7-1.25
High Estimate-0.43-0.39-1.63-0.95
Year Ago EPS-1.4-0.9-5.41-1.66
Revenue EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts1122
Avg. Estimate7.25M9.5M29.89M52.75M
Low Estimate7.25M9.5M29.78M47.5M
High Estimate7.25M9.5M30M58M
Year Ago SalesN/A1.29M5.03M29.89M
Sales Growth (year/est)N/A635.90%494.60%76.50%
Earnings History6/29/20209/29/202012/30/20203/30/2021
EPS Est.-1.6-0.97-0.95-0.67
EPS Actual-1.4-0.9-1.11-0.53
Difference0.20.07-0.160.14
Surprise %12.50%7.20%-16.80%20.90%
EPS TrendCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Current Estimate-0.43-0.39-1.66-1.1
7 Days Ago-0.41-0.37-1.95-1.22
30 Days Ago-0.45-0.47-2.02-1.35
60 Days Ago-0.57-0.58-2.22-1.17
90 Days Ago-0.7-0.7-3.37-2.1
EPS RevisionsCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Up Last 7 DaysN/AN/A21
Up Last 30 DaysN/AN/A22
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days11N/AN/A
Growth EstimatesNBRVIndustrySector(s)S&P 500
Current Qtr.69.30%N/AN/AN/A
Next Qtr.56.70%N/AN/AN/A
Current Year69.30%N/AN/AN/A
Next Year33.70%N/AN/AN/A
Next 5 Years (per annum)97.20%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A